![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-desktop-headergif-72716.gif)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-mob-headergif-95876.gif)
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.globenewswire.com/news-release/2024/04/16/2863440/0/en/Marizyme-Enters-Into-Co-Development-Agreement-With-Qualigen-Therapeutics-for-the-Commercialization-of-FDA-Cleared-DuraGraft.html
https://www.globenewswire.com//news-release/2023/10/23/2764767/0/en/Marizyme-CEO-Delivers-Business-Update.html
https://www.globenewswire.com//news-release/2023/10/06/2756102/0/en/Marizyme-Inc-Announces-FDA-Clearance-for-Flagship-Product-DuraGraft.html
https://www.globenewswire.com/news-release/2023/05/03/2660275/0/en/Marizyme-CEO-Delivers-Business-Update.html
https://www.globenewswire.com/news-release/2021/12/23/2357572/0/en/Marizyme-Announces-the-Closing-of-My-Health-Logic-Acquisition-Along-With-Initial-Financing.html
https://www.globenewswire.com/news-release/2021/12/23/2357572/0/en/Marizyme-Announces-the-Closing-of-My-Health-Logic-Acquisition-Along-With-Initial-Financing.html
https://www.globenewswire.com/news-release/2021/12/03/2346060/0/en/Marizyme-Inc-Announces-Results-of-GOAL-Study-Presented-at-7th-Annual-International-Coronary-Congress.html
https://www.globenewswire.com/news-release/2021/12/03/2345916/0/en/Marizyme-Announces-Expansion-of-Patent-Portfolio-Into-Several-Key-Territories.html